ArticleEJNMMI research2026

Correction: Combined antitumor activity of [177Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein.

Jing-Ren Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.